GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Bought by California Public Employees Retirement System

California Public Employees Retirement System raised its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 1.4% during the fourth quarter, HoldingsChannel.com reports. The firm owned 845,697 shares of the company’s stock after buying an additional 11,746 shares during the period. California Public Employees Retirement System’s holdings in GE HealthCare Technologies were worth $65,389,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the company. AE Wealth Management LLC grew its stake in shares of GE HealthCare Technologies by 4.0% in the third quarter. AE Wealth Management LLC now owns 10,810 shares of the company’s stock worth $735,000 after purchasing an additional 420 shares in the last quarter. IFP Advisors Inc grew its stake in shares of GE HealthCare Technologies by 53.8% in the third quarter. IFP Advisors Inc now owns 2,320 shares of the company’s stock worth $158,000 after purchasing an additional 812 shares in the last quarter. Avior Wealth Management LLC grew its stake in shares of GE HealthCare Technologies by 35.5% in the third quarter. Avior Wealth Management LLC now owns 1,369 shares of the company’s stock worth $93,000 after purchasing an additional 359 shares in the last quarter. Private Trust Co. NA grew its stake in shares of GE HealthCare Technologies by 53.9% in the third quarter. Private Trust Co. NA now owns 1,808 shares of the company’s stock worth $123,000 after purchasing an additional 633 shares in the last quarter. Finally, SS&H Financial Advisors Inc. bought a new position in shares of GE HealthCare Technologies in the third quarter worth $334,000. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Down 0.9 %

Shares of GE HealthCare Technologies stock opened at $85.95 on Friday. The stock has a 50-day moving average price of $88.91 and a 200 day moving average price of $78.32. The company has a market cap of $39.22 billion, a P/E ratio of 28.46, a P/E/G ratio of 3.02 and a beta of 0.94. The company has a current ratio of 1.05, a quick ratio of 0.83 and a debt-to-equity ratio of 1.18. GE HealthCare Technologies Inc. has a 1 year low of $62.35 and a 1 year high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share for the quarter, topping analysts’ consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The company had revenue of $5.20 billion during the quarter, compared to the consensus estimate of $5.09 billion. During the same period last year, the business earned $1.31 EPS. The business’s quarterly revenue was up 5.3% on a year-over-year basis. As a group, analysts expect that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be paid a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. The ex-dividend date of this dividend is Thursday, April 18th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.97%.

Analyst Upgrades and Downgrades

GEHC has been the subject of several research reports. Evercore ISI raised their target price on GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a research note on Thursday, April 4th. Argus raised their target price on GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a research note on Monday, April 1st. Citigroup raised their target price on GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a research note on Wednesday, April 3rd. Mizuho increased their price target on GE HealthCare Technologies from $96.00 to $110.00 and gave the company a “buy” rating in a research report on Thursday, April 11th. Finally, UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and increased their price target for the company from $66.00 to $88.00 in a research report on Monday, February 12th. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $95.09.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.